Cerhan JR - Search Results

1

Targeting of inflammatory pathways with R2CHOP in high-risk DLBCL.

Hartert KT, Wenzl K, Krull JE, Manske M, Sarangi V, Asmann Y, Larson MC, Maurer MJ, Slager S, Macon WR, King RL, Feldman AL, Gandhi AK, Link BK, Habermann TM, Yang ZZ, Ansell SM, Cerhan JR, Witzig TE, Nowakowski GS, Novak AJ. Hartert KT, et al. Among authors: cerhan jr. Leukemia. 2021 Feb;35(2):522-533. doi: 10.1038/s41375-020-0766-4. Epub 2020 Mar 5. Leukemia. 2021. PMID: 32139889 Free PMC article. Clinical Trial.

2

Smoking and risk of non-Hodgkin lymphoma subtypes in a cohort of older women.

Parker AS, Cerhan JR, Dick F, Kemp J, Habermann TM, Wallace RB, Sellers TA, Folsom AR. Parker AS, et al. Among authors: cerhan jr. Leuk Lymphoma. 2000 Apr;37(3-4):341-9. doi: 10.3109/10428190009089434. Leuk Lymphoma. 2000. PMID: 10752985

3

Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States).

Cerhan JR, Habermann TM, Vachon CM, Putnam SD, Zheng W, Potter JD, Folsom AR. Cerhan JR, et al. Cancer Causes Control. 2002 Mar;13(2):131-6. doi: 10.1023/a:1014354105164. Cancer Causes Control. 2002. PMID: 11936819

4

Analysis of the RNASEL gene in familial and sporadic prostate cancer.

Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN. Wang L, et al. Among authors: cerhan jr. Am J Hum Genet. 2002 Jul;71(1):116-23. doi: 10.1086/341281. Epub 2002 May 17. Am J Hum Genet. 2002. PMID: 12022038 Free PMC article.

5

Anthropometric characteristics, physical activity, and risk of non-Hodgkin's lymphoma subtypes and B-cell chronic lymphocytic leukemia: a prospective study.

Cerhan JR, Janney CA, Vachon CM, Habermann TM, Kay NE, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Am J Epidemiol. 2002 Sep 15;156(6):527-35. doi: 10.1093/aje/kwf082. Am J Epidemiol. 2002. PMID: 12226000

6

Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.

Cerhan JR, Vachon CM, Habermann TM, Ansell SM, Witzig TE, Kurtin PJ, Janney CA, Zheng W, Potter JD, Sellers TA, Folsom AR. Cerhan JR, et al. Cancer Epidemiol Biomarkers Prev. 2002 Nov;11(11):1466-71. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12433728

7

Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma.

Cerhan JR, Anderson KE, Janney CA, Vachon CM, Witzig TE, Habermann TM. Cerhan JR, et al. Int J Cancer. 2003 Sep 20;106(5):784-8. doi: 10.1002/ijc.11311. Int J Cancer. 2003. PMID: 12866040 Free article. Clinical Trial.

8

No association of germline alteration of MSR1 with prostate cancer risk.

Wang L, McDonnell SK, Cunningham JM, Hebbring S, Jacobsen SJ, Cerhan JR, Slager SL, Blute ML, Schaid DJ, Thibodeau SN. Wang L, et al. Among authors: cerhan jr. Nat Genet. 2003 Oct;35(2):128-9. doi: 10.1038/ng1239. Epub 2003 Sep 7. Nat Genet. 2003. PMID: 12958598

9

Clinical characteristics of familial vs. sporadic non-Hodgkin lymphoma in patients diagnosed at the Mayo Clinic (1986-2000).

Vachon CM, Habermann TM, Kurtin PJ, Cerhan JR. Vachon CM, et al. Among authors: cerhan jr. Leuk Lymphoma. 2004 May;45(5):929-35. doi: 10.1080/1042819032000159898. Leuk Lymphoma. 2004. PMID: 15291351

10

Elevated serum B-lymphocyte stimulator levels in patients with familial lymphoproliferative disorders.

Novak AJ, Grote DM, Ziesmer SC, Kline MP, Manske MK, Slager S, Witzig TE, Shanafelt T, Call TG, Kay NE, Jelinek DF, Cerhan JR, Gross JA, Harder B, Dillon SR, Ansell SM. Novak AJ, et al. Among authors: cerhan jr. J Clin Oncol. 2006 Feb 20;24(6):983-7. doi: 10.1200/JCO.2005.02.7938. Epub 2006 Jan 23. J Clin Oncol. 2006. PMID: 16432079

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

599 results

Search Page